Clinical Guidelines
Feature
ASCRS 2026: New Data Highlight Performance of TECNIS PureSee EDOF IOL
New data highlight visual outcomes and patient experience
Johnson & Johnson will reveal new clinical and real-world data regarding its TECNIS PureSee intraocular lens (IOL) at the 2026 ASCRS Annual Meeting in Washington, DC. This lens is an FDA-approved extended depth of focus (EDOF) IOL designed to enhance vision beyond that offered by standard monofocal lenses. Recent studies, including a US randomized trial and a large observational study, demonstrated improved distance, intermediate, and near vision while maintaining patient satisfaction and low visual disturbance rates. The results indicate significant advantages over traditional options.
